<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biosciences Biotechnology Research Asia</journalTitle>
          <issn>0973-1245</issn>
            <publicationDate>2024-12-20</publicationDate>
    
        <volume>21</volume>
        <issue>4</issue>

 
    <startPage>1593</startPage>
    <endPage>1604</endPage>

	 
      <doi>10.13005/bbra/3328</doi>
        <publisherRecordId>53359</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Box-Behnken Design Assisted AQbD Approach for the Optimization and Quality Assessment of Ensitrelvir in Bulk and Dosage forms by RP-HPLC</title>

    <authors>
	 


      <author>
       <name>Sivagami B</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Dinesh MV</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	 


      <author>
       <name>Pavan Kumar V</name>

		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Chandrasekar R</name>

		
	<affiliationId>2</affiliationId>
      </author>
    


	 


      <author>
       <name>Sanjeeva Kumar A</name>

		
	<affiliationId>2</affiliationId>
      </author>
    


	 


      <author>
       <name>Satheesh Kumar G</name>

		
	<affiliationId>3</affiliationId>
      </author>
    
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Pharmaceutical Analysis, Faculty of Pharmacy, Seven Hills College of Pharmacy, Tirupati, Andhra Pradesh, India.</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Pharmacognosy, Seven Hills College of Pharmacy, Tirupati, 517561, Andhra Pradesh, India.</affiliationName>
    
		
		<affiliationName affiliationId="3">Department of Pharmaceutical Chemistry, Seven Hills College of Pharmacy, Tirupati, Andhra Pradesh, India.</affiliationName>
    
		
		
		
	  </affiliationsList>






    <abstract language="eng">Ensitrelvir, is an oral SARS-CoV-2 3CL protease inhibitor that was approved in Japan to treat SARS-CoV-2 infections. This paper describes the AQbD approach and Box Behnken Design assisted development of a HPLC method and its validation for Ensitrelvir in bulk and dosage form. The three independent variables of the RP-HPLC method were flow rate, organic ratio in mobile phase and runtime and the responses retention time and tailing factor were taken as dependent variables. The study utilized a PLATSIL C18-EP column (4.6 x 250mm, 5µm) the chromatographic conditions were optimized using Acetonitrile: Triethylamine pH: 4 (60:40 mL) as the mobile phase, 1 mL/min as flow rate with a Rt of 9.609 min, at a λ max of 228 nm. The devised technique was found to be linear with a serial dilution of 10–50 μg/ml with (r<sup>2</sup>) of 0.991. The tailing factor (TF) and theoretical plates (N) were 1.28 and 4883 results indicated the system suitability test, respectively. The precision for Intraday and Interday were determined and % RSD was observed to be 1.6 and 0.9 %. The robustness values were below 2%. No other coeluting peaks were found with the Ensitrelvir peak, according to the chromatographic peak purity data. According to ICH specifications, the parameters for method validation were within the permissible range.</abstract>

    <fullTextUrl format="html">https://www.biotech-asia.org/vol21no4/box-behnken-design-assisted-aqbd-approach-for-the-optimization-and-quality-assessment-of-ensitrelvir-in-bulk-and-dosage-forms-by-rp-hplc/</fullTextUrl>



      <keywords language="eng">
        <keyword><p style="text-align: justify; line-height: 150%;">Analytical Quality by Design; Box-Behnken Design; Ensitrelvir; Optimization; RP-HPLC</p></keyword>
      </keywords>

  </record>
</records>